Journals / Göztepe Tıp Dergisi / 2014 / Cilt: 29 - Sayı: 3

Surgical, functional and oncological outcomes of robot-assisted partial nephrectomy

Robot yardımlı parsiyel nefrektomi olgularının cerrahi, fonksiyonel ve onkolojik sonuçları

Pages
154–159
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RPN is an effective and reliable treatment alternative in patients who are amenable to nephron sparing surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In this study, we aimed to evaluate surgical, functional and oncolojical outcomes of robotic partial nephrectomy in patients with cT1 renal tumors.
📊
Key Findings & Data:Materials and Methods: Between August 2008 and May 2013, 45 patients with c T1a-b renal tumors underwent robotic partial nephrectomy (RPN) were included in this study.
💡
Conclusion & Impact:RPN is an effective and reliable treatment alternative in patients who are amenable to nephron sparing surgery.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: In this study, we aimed to evaluate surgical, functional and oncolojical outcomes of robotic partial nephrectomy in patients with cT1 renal tumors. Materials and Methods: Between August 2008 and May 2013, 45 patients with c T1a-b renal tumors underwent robotic partial nephrectomy (RPN) were included in this study. Patients’ demographics, mean operative time, estimated blood loss, warm ischemia time, hospital stay, complications, oncologic outcomes were evaluated retrospectively. Statistical analyses were done using with SPSS Statistics v.20 (IBM, Armonk, NY, USA) software. Results: Mean age of the patients, tumor size and R.E.N.A.L nephrometry scores were 55±11 years, 3.56±1,3 cm and 5.36±1.55 (range=4-10), respectively. All patients underwent 4 or 5 port robotic partial nephrectomy via transperitoneal approach. The mean operation time and estimated blood loss were 133±45 min and 210±130 ml (range, 50-2100 ml), respectively. Warm ischemia time was 23.5±8,4 min. Drain removal time was 3,2±1 days after surgery. Length of hospital stay was 4.3±1.5 days (range, 2-8 days). No complications occurred intraoperatively. Eight patients had Clavien grade 1 or 2 postoperative complications. Thirty-seven tumors (82.2 %) were malignant as indicated in final pathology reports of the resected 45 tumors. Surgical margin was positive in one patient. However, there were any local recurrence during an average of 25 month-follow-up period. Conclusion: Partial nephrectomy is the current gold standart treatment modality in patient with c T1 renal tumors. RPN is an effective and reliable treatment alternative in patients who are amenable to nephron sparing surgery.

Özet

Amaç: Biz bu çalışmada klinik evre T1 böbrek tümörelerinde robotik parsiyel nefrektominin (RPN) cerrahi, fonksiyonel ve onkolojik sonuçlarını değerlendirmeyi amaçladık.Gereç ve Yöntem: Ağustos 2008 ve Mayıs 2013 tarihleri arasında, klinik evre T1a-b böbrek tümörü sebebiyle RPN yapılan 45 hasta çalışmaya dâhil edildi. Hastaların demografik özellikleri, ortalama operasyon süresi, tahmini kan kaybı, sıcak iskemi süresi, hastanede kalış süresi, komplikasyonlar ve onkolojik sonuçlar retrospektif olarak değerlendirildi. İstatistiksel analiz SPSS v.20 (IBM, Armonk, NY, USA) bilgisayar yazılımı kullanılarak yapıldı.Bulgular: Ortalama hasta yaşı, tümor boyutu ve R.E.N.A.L nefrometri skoru sırasıyla 55±11 yıl, 3,56±1,3 cm, 5,36±1,55 idi. Hastaların tamamına 4 ya da 5 port kullanılarak transperitoneal RPN yapıldı. Ortalama operasyon süresi ve tahmini kan kaybı sırasıyla 133±45 dk. ve 210±30 mililitre idi. Sıcak iskemi süresi 23,5±8,4 dk. idi. Dren operasyon sonrası 3,2±1 günde alındı. Hastanede kalış süresi 4,3±1,5 gündü . İntraoperatif herhangi bir komplikasyonla karşılaşılmadı. Postoperatif olarak 8 hastada Clavien evre 1-2 komplikasyon gelişti. Final patolojide 45 tümörün 37'si maligndi (% 82,2). Cerrahi sınır bir hastada pozitifti. Buna rağmen, ortalama 25 aylık takip döneminde local rekürrens ile karşılaşılmadı.Sonuç: Parsiyel nefrektomi günümüzde klinik evre T1 böbrek tümörü olan hastalarda altın standart tedavi yöntemidir. RPN nefron koruyucu cerrahiye uygun hastalarda etkin ve güvenilir bir minimal invazif tedavi alternatifidir

🔖

Cite This Article

BOYLU, U., ÖNOL, F. F., GÜMÜŞ, E., BAŞATAÇ, C., YILDIRIM, Ü. (2022). Surgical, functional and oncological outcomes of robot-assisted partial nephrectomy. Göztepe Tıp Dergisi, Cilt: 29 - Sayı: 3, 154–159. https://ajindex.com/articles/524119

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Belldegrun A, Tsui KH, deKernion JB, Smith RB. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol 1999;17:2868-75
  2. Hollingsworth JM, Miller DC, Dunn RL, Montgomery JS, Roberts WW, Hafez KS et al. Surgical management of lowstage renal cell carcinoma: Technology does not supersede biology. Urology 2006;67:1175-80.
  3. Shuch B, Lam JS, Belldegrun AS. Open partial nephrectomy for the treatment of renal cell carcinoma. Curr Urol Rep 2006;7:31-38.
  4. Burgess NA, Koo BC, Calvert RC, Hindmarsh A, Donaldson PJ, Rhodes M. Randomized trial of laparoscopic v open nephrectomy. J Endourol 2007;21:610-13.
  5. Porpiglia F, Volpe A, Billia M, Scarpa RM. Laparoscopic versus open partial nephrectomy: analysis of the current literature. Eur Urol 2008;53:732-43.
  6. Kural AR, Atuğ F. The applications of robotic surgery in urology. [Article in Turkish] Türk Üroloji Dergisi 2010;36:248-57.
  7. Dindo D, Demartines N, Clavien PA. Classifications of surgical complications: a new proposal evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-13. ttp://dx.doi.org/10.1097/01.sla.0000133083.54934.ae 8. Tan HJ, Norton EC, Ye Z, Hafez KS, Gore JL, Miller DC. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA 2012;307:1629-35.
  8. Marszalek M, Meixl H, Polajnar M, Rauchenwald M, Jeschke K, Madersbacher S. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients. Eur Urol 2009;55:1171-78
  9. Peycelon M, Hupertan V, Comperat E, Renard-Penna R, Vaessen C, Conort P et al. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm. J Urol 2009;181:35-41.
  10. Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007;178:41-46.
  11. Delakas D, Karyotis I, Daskalopoulos G, Terhorst B, Lymberopoulos S, Cranidis A. Nephron-sparing surgery for localized renal cell carcinoma with a normal contralat